TrialArthritis research & therapy2020

Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.